A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults

Completed · Phase 3

Conditions studied: Meningococcal Infections, Meningococcal Meningitis

In brief

This study will evaluate the lot to lot consistency, safety and immune response of the Novartis Meningococcal ACWY conjugate vaccine in healthy US adolescents and adults.

Key facts

Study ID

NCT00450437

Run by

Novartis Vaccines

People needed

3539

Starts

2007-03-01

Expected to finish

2008-01-01

Last updated by the study team

2015-01-28

Who can join

Age: 11 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Healthy subjects who are 11-55 years of age inclusive and who have given appropriate written assent and/or consent

You may not qualify if…

• Subjects with a previous or suspected disease caused by N. meningitidis
• previous immunization with a meningococcal vaccine or vaccine containing meningococcal antigen(s)
• previous or suspected disease caused by N. meningitidis
• Any serious acute, chronic or progressive disease
• Pregnant or breastfeeding

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Tuscaloosa, Alabama, United States
• Study site — Fremont, California, United States
• Study site — Fresno, California, United States
• Study site — Hayward, California, United States
• Study site — Oakland, California, United States
• Study site — Roseville, California, United States
• Study site — Sacramento, California, United States
• Study site — San Jose, California, United States
• Study site — Denver, Colorado, United States
• Study site — Atlanta, Georgia, United States
• Study site — Marietta, Georgia, United States
• Study site — Woodstock, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Bardstown, Kentucky, United States
• Study site — Annapolis, Maryland, United States
• Study site — Baltimore, Maryland, United States
• Study site — Frederick, Maryland, United States
• Study site — Boston, Massachusetts, United States
• Study site — Fall River, Massachusetts, United States
• Study site — Lebanon, New Hampshire, United States
• Study site — Akron, Ohio, United States
• Study site — Cincinnati, Ohio, United States
• Study site — South Euclid, Ohio, United States
• Study site — Carnegie, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.